SEC Form 4 reporting owner

Nougues Maximo F

Nougues Maximo F has filed 5 Form 4 transactions reported between January 6, 2026 and July 6, 2026, as Chief Financial Officer of PUMA BIOTECHNOLOGY, INC..

Name as filed: NOUGUES MAXIMO F

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$142K
3 lines
Companies
1
with Form 4 filings
Latest transaction
Jul 6, 2026
transaction date

Roles and reported holdings

  • PBYIPUMA BIOTECHNOLOGY, INC.
    Jan 6, 2026 – Jul 6, 2026

    Chief Financial Officer

    Held directly230,637 sh as of Jul 6, 2026 · Form 4

    24 months: $142K sold

Transaction history

All 5 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jul 6, 2026PBYIChief Financial OfficerOpen-market saleCode S · direct9,386$78K@ $8.26Form 4
Feb 18, 2026PBYIChief Financial OfficerGrant or awardCode A · direct66,541—Form 4
Feb 18, 2026PBYIChief Financial OfficerGrant or awardCode A · direct46,739—Form 4
Jan 7, 2026PBYIChief Financial OfficerOpen-market saleCode S · direct6,405$38K@ $5.88Form 4
Jan 6, 2026PBYIChief Financial OfficerOpen-market saleCode S · direct4,540$27K@ $5.84Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.